India cites deliberate "generic" vs. "counterfeit" confusion

The persistent seizure of Indian generics at European ports may be a terminology issue. A representative from India, speaking at a World Health Organization meeting, suggests that port authorities may be confusing the terms "counterfeit" and "generic."

India says the EU has provided information on 26 drug-shipment seizures in 17 European countries relating to intellectual-property violations. But Indian officials are still waiting to hear if European authorities found any substandard medicines, Intellectual Property Watch reports.

European officials say that such mistaken seizure of legitimate generic drugs ended in 2008.

"We have concerns regarding the use of the term 'counterfeit,'" India says in a statement to the meeting. The term "counterfeit" is more closely aligned with trademark issues rather than the quality, safety and efficacy issues that should drive health officials' judgments concerning drug shipments, say representatives from India, Brazil and other countries. The intellectual-property perspective introduces a "deliberate confusion" of the issue by those who want to increase IP enforcement.

- read the article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.